Related Experiment Video
Updated: Sep 1, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Worenine Prevents Solar Ultraviolet-Induced Sunburn by Inhibiting JNK2
Juanjuan Xiao1,2, Hui Lu3,4, Tengfei Ma4
1Cancer Research Institute, The Affiliated Hospital of Guilin Medical University, Guilin, China.
Abstract:
Excessive solar ultraviolet (SUV) radiation often causes dermatitis, photoaging, and even skin cancer. In the pathological processes of SUV-induced sunburn, JNK is activated by phosphorylation, and it in turn phosphorylates its downstream transcription factors, such as ATF2 and c-jun. The transcription factors further regulate the expression of pro-inflammatory genes, such as IL-6 and TNF-α, which ultimately leads to dermatitis. Therefore, inhibiting JNK may be a strategy to prevent dermatitis. In this study, we screened for worenine as a potential drug candidate for inhibiting sunburn. We determined that worenine inhibited the JNK-ATF2/c-jun signaling pathway and the secretion of IL-6 and TNF-α in cell culture and in vivo, confirming the role of worenine in inhibiting sunburn. Furthermore, we determined that worenine bound and inhibited JNK2 activity in vitro through the MST, kinase, and in vitro kinase assays. Therefore, worenine might be a promising drug candidate for the prevention and treatment of SUV-induced sunburn.
Insights
Worenine effectively inhibits the JNK signaling pathway, reducing inflammation and protecting against sunburn. This compound shows promise as a therapeutic agent for solar ultraviolet radiation-induced skin damage.
Area of Science:
- Dermatology
- Molecular Biology
- Pharmacology
Background:
- Excessive solar ultraviolet (SUV) radiation causes skin damage, including dermatitis and photoaging.
- SUV-induced sunburn involves the activation of the c-Jun N-terminal kinase (JNK) pathway.
- This pathway upregulates pro-inflammatory genes like IL-6 and TNF-α, contributing to dermatitis.
Purpose of the Study:
- To identify potential therapeutic agents for preventing SUV-induced sunburn.
- To investigate worenine as a candidate drug for inhibiting sunburn.
- To elucidate the molecular mechanism of worenine's action.
Main Methods:
- Screening for potential sunburn inhibitors.
- Evaluating worenine's effect on the JNK-ATF2/c-jun signaling pathway in cell culture and in vivo.
- Assessing worenine's inhibitory activity against JNK2 using MST and kinase assays.
Main Results:
- Worenine demonstrated inhibition of the JNK-ATF2/c-jun signaling pathway.
- Worenine suppressed the secretion of IL-6 and TNF-α.
- In vitro assays confirmed that worenine binds to and inhibits JNK2 activity.
Conclusions:
- Worenine effectively inhibits the JNK signaling pathway, a key mediator of sunburn.
- Worenine reduces the expression of inflammatory markers associated with sunburn.
- Worenine is a promising drug candidate for preventing and treating SUV-induced sunburn.
Related Concept Videos
Inhibition of Cdk Activity
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Canonical Wnt Signaling Pathway

